{"entity":{"type":"insider","cik":"0001853529","url":"/insider/0001853529","json_url":"/insider/0001853529.json","name":"Russell Alan J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":23,"first":"2021-09-27","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Russell Alan J","source":"filing","n_filings":23,"first_seen":"2021-09-27","last_seen":"2026-08-14"}],"transactions":[{"id":9296492,"accession":"0001853529-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001853529-26-000002","line_url":"/filing/0001853529-26-000002","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5901.0,"shares_display":"5,901","price_per_share":43.72859950855787,"price_display":"43.73","price_state":"stated","total_value":258042.4657,"total_display":"258,042.47","total_whole":"258,042","shares_owned_after":34129.0,"shares_owned_after_display":"34,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider","n_lines":3},{"id":5900324,"accession":"0001853529-26-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001853529-26-000001","line_url":"/filing/0001853529-26-000001","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":39.407009896,"price_display":"39.41","price_state":"stated","total_value":7881401.9792,"total_display":"7,881,401.98","total_whole":"7,881,402","shares_owned_after":94203.0,"shares_owned_after_display":"94,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":2},{"id":4103674,"accession":"0001853529-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001853529-25-000007","line_url":"/filing/0001853529-25-000007#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":21.1245,"price_display":"21.12","price_state":"stated","total_value":2112450.0,"total_display":"2,112,450.00","total_whole":"2,112,450","shares_owned_after":23400.0,"shares_owned_after_display":"23,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-13","scope":"insider"},{"id":4898523,"accession":"0001853529-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001853529-25-000003","line_url":"/filing/0001853529-25-000003#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":14.5976,"price_display":"14.60","price_state":"stated","total_value":1459760.0,"total_display":"1,459,760.00","total_whole":"1,459,760","shares_owned_after":23400.0,"shares_owned_after_display":"23,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":5015609,"accession":"0001562180-25-005796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-005796","line_url":"/filing/0001562180-25-005796#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1907.0,"shares_display":"1,907","price_per_share":13.3924,"price_display":"13.39","price_state":"stated","total_value":25539.3068,"total_display":"25,539.31","total_whole":"25,539","shares_owned_after":23400.0,"shares_owned_after_display":"23,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4821805,"accession":"0001562180-25-003660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-003660","line_url":"/filing/0001562180-25-003660#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1551.0,"shares_display":"1,551","price_per_share":16.4542,"price_display":"16.45","price_state":"stated","total_value":25520.4642,"total_display":"25,520.46","total_whole":"25,520","shares_owned_after":18521.0,"shares_owned_after_display":"18,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-07","scope":"insider"},{"id":4568873,"accession":"0001562180-25-002294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-002294","line_url":"/filing/0001562180-25-002294#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":30.02,"price_display":"30.02","price_state":"stated","total_value":6004.0,"total_display":"6,004.00","total_whole":"6,004","shares_owned_after":14863.0,"shares_owned_after_display":"14,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-11","scope":"insider"},{"id":4473156,"accession":"0001562180-25-001026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-25-001026","line_url":"/filing/0001562180-25-001026#line-4","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":30.1275,"price_display":"30.13","price_state":"stated","total_value":36153.0,"total_display":"36,153.00","total_whole":"36,153","shares_owned_after":14863.0,"shares_owned_after_display":"14,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-06","filed_date":"2025-02-07","scope":"insider"},{"id":4473150,"accession":"0001562180-25-001026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-001026","line_url":"/filing/0001562180-25-001026#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8015.0,"shares_display":"8,015","price_per_share":30.0216,"price_display":"30.02","price_state":"stated","total_value":240623.124,"total_display":"240,623.12","total_whole":"240,623","shares_owned_after":14863.0,"shares_owned_after_display":"14,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-07","scope":"insider"},{"id":2403267,"accession":"0001562180-24-008663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-008663","line_url":"/filing/0001562180-24-008663#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":27.3747,"price_display":"27.37","price_state":"stated","total_value":2737470.0,"total_display":"2,737,470.00","total_whole":"2,737,470","shares_owned_after":14863.0,"shares_owned_after_display":"14,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2024-12-31","scope":"insider"},{"id":3083657,"accession":"0001562180-24-006947","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-006947","line_url":"/filing/0001562180-24-006947","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":28.268015933333334,"price_display":"28.27","price_state":"stated","total_value":2120101.195,"total_display":"2,120,101.20","total_whole":"2,120,101","shares_owned_after":13534.0,"shares_owned_after_display":"13,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider","n_lines":2},{"id":2481597,"accession":"0001562180-24-003827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-003827","line_url":"/filing/0001562180-24-003827#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1576.0,"shares_display":"1,576","price_per_share":18.91,"price_display":"18.91","price_state":"stated","total_value":29802.16,"total_display":"29,802.16","total_whole":"29,802","shares_owned_after":7238.0,"shares_owned_after_display":"7,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":8558544,"accession":"0001562180-23-008571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-008571","line_url":"/filing/0001562180-23-008571#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172585.0,"shares_display":"172,585","price_per_share":9.3293,"price_display":"9.33","price_state":"stated","total_value":1610097.2405,"total_display":"1,610,097.24","total_whole":"1,610,097","shares_owned_after":3606.0,"shares_owned_after_display":"3,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":7908001,"accession":"0001562180-23-003920","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-003920","line_url":"/filing/0001562180-23-003920#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1602.0,"shares_display":"1,602","price_per_share":8.9049,"price_display":"8.90","price_state":"stated","total_value":14265.6498,"total_display":"14,265.65","total_whole":"14,266","shares_owned_after":176191.0,"shares_owned_after_display":"176,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"},{"id":4265287,"accession":"0001562180-21-007134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-007134","line_url":"/filing/0001562180-21-007134","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":479.0,"shares_display":"479","price_per_share":19.113575782881004,"price_display":"19.11","price_state":"stated","total_value":9155.4028,"total_display":"9,155.40","total_whole":"9,155","shares_owned_after":38.0,"shares_owned_after_display":"38","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider","n_lines":2},{"id":4698483,"accession":"0001562180-21-007025","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-21-007025","line_url":"/filing/0001562180-21-007025#line-7","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8562.0,"shares_display":"8,562","price_per_share":19.5134,"price_display":"19.51","price_state":"stated","total_value":167073.7308,"total_display":"167,073.73","total_whole":"167,074","shares_owned_after":479.0,"shares_owned_after_display":"479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-12","scope":"insider"},{"id":4698478,"accession":"0001562180-21-007025","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-21-007025","line_url":"/filing/0001562180-21-007025","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19276.0,"shares_display":"19,276","price_per_share":19.93351649719859,"price_display":"19.93","price_state":"stated","total_value":384238.464,"total_display":"384,238.46","total_whole":"384,238","shares_owned_after":12722.0,"shares_owned_after_display":"12,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider","n_lines":2},{"id":4698472,"accession":"0001562180-21-007025","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-007025","line_url":"/filing/0001562180-21-007025","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12326.0,"shares_display":"12,326","price_per_share":19.72819923738439,"price_display":"19.73","price_state":"stated","total_value":243169.7838,"total_display":"243,169.78","total_whole":"243,170","shares_owned_after":28897.0,"shares_owned_after_display":"28,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider","n_lines":2},{"id":4698465,"accession":"0001562180-21-007025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-007025","line_url":"/filing/0001562180-21-007025","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29576.0,"shares_display":"29,576","price_per_share":20.094185285366514,"price_display":"20.09","price_state":"stated","total_value":594305.624,"total_display":"594,305.62","total_whole":"594,306","shares_owned_after":53355.0,"shares_owned_after_display":"53,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-12","scope":"insider","n_lines":2},{"id":5496303,"accession":"0001562180-21-006901","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-006901","line_url":"/filing/0001562180-21-006901#line-4","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9017.0,"shares_display":"9,017","price_per_share":20.1646,"price_display":"20.16","price_state":"stated","total_value":181824.1982,"total_display":"181,824.20","total_whole":"181,824","shares_owned_after":70219.0,"shares_owned_after_display":"70,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-08","scope":"insider"},{"id":5496300,"accession":"0001562180-21-006901","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-006901","line_url":"/filing/0001562180-21-006901","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13042.0,"shares_display":"13,042","price_per_share":19.6217962582426,"price_display":"19.62","price_state":"stated","total_value":255907.4668,"total_display":"255,907.47","total_whole":"255,907","shares_owned_after":79236.0,"shares_owned_after_display":"79,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-08","scope":"insider","n_lines":2},{"id":5496295,"accession":"0001562180-21-006901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006901","line_url":"/filing/0001562180-21-006901#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7392.0,"shares_display":"7,392","price_per_share":19.7635,"price_display":"19.76","price_state":"stated","total_value":146091.792,"total_display":"146,091.79","total_whole":"146,092","shares_owned_after":92278.0,"shares_owned_after_display":"92,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-08","scope":"insider"},{"id":5496281,"accession":"0001562180-21-006811","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-21-006811","line_url":"/filing/0001562180-21-006811","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26184.0,"shares_display":"26,184","price_per_share":18.18269498548732,"price_display":"18.18","price_state":"stated","total_value":476095.6855,"total_display":"476,095.69","total_whole":"476,096","shares_owned_after":105032.0,"shares_owned_after_display":"105,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-03","scope":"insider","n_lines":3},{"id":5496271,"accession":"0001562180-21-006811","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-006811","line_url":"/filing/0001562180-21-006811#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17519.0,"shares_display":"17,519","price_per_share":17.4302,"price_display":"17.43","price_state":"stated","total_value":305359.6738,"total_display":"305,359.67","total_whole":"305,360","shares_owned_after":125854.0,"shares_owned_after_display":"125,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":5496270,"accession":"0001562180-21-006811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006811","line_url":"/filing/0001562180-21-006811#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":469.0,"shares_display":"469","price_per_share":18.0246,"price_display":"18.02","price_state":"stated","total_value":8453.5374,"total_display":"8,453.54","total_whole":"8,454","shares_owned_after":143373.0,"shares_owned_after_display":"143,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4637809,"accession":"0001562180-21-006498","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-006498","line_url":"/filing/0001562180-21-006498","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1433.0,"shares_display":"1,433","price_per_share":18.1201199581298,"price_display":"18.12","price_state":"stated","total_value":25966.1319,"total_display":"25,966.13","total_whole":"25,966","shares_owned_after":143968.0,"shares_owned_after_display":"143,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-18","scope":"insider","n_lines":2},{"id":4637804,"accession":"0001562180-21-006498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006498","line_url":"/filing/0001562180-21-006498#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5749.0,"shares_display":"5,749","price_per_share":18.18,"price_display":"18.18","price_state":"stated","total_value":104516.82,"total_display":"104,516.82","total_whole":"104,517","shares_owned_after":145275.0,"shares_owned_after_display":"145,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-18","scope":"insider"},{"id":5376584,"accession":"0001562180-21-006455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006455","line_url":"/filing/0001562180-21-006455#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":22885.4,"total_display":"22,885.40","total_whole":"22,885","shares_owned_after":151024.0,"shares_owned_after_display":"151,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-13","scope":"insider"},{"id":5496217,"accession":"0001562180-21-006391","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-006391","line_url":"/filing/0001562180-21-006391#line-3","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5902.0,"shares_display":"5,902","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":107121.3,"total_display":"107,121.30","total_whole":"107,121","shares_owned_after":152294.0,"shares_owned_after_display":"152,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-08","scope":"insider"},{"id":5496215,"accession":"0001562180-21-006391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-006391","line_url":"/filing/0001562180-21-006391#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13018.0,"shares_display":"13,018","price_per_share":18.56,"price_display":"18.56","price_state":"stated","total_value":241614.08,"total_display":"241,614.08","total_whole":"241,614","shares_owned_after":158196.0,"shares_owned_after_display":"158,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-07","filed_date":"2021-10-08","scope":"insider"},{"id":5496212,"accession":"0001562180-21-006391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006391","line_url":"/filing/0001562180-21-006391#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2108.0,"shares_display":"2,108","price_per_share":18.03,"price_display":"18.03","price_state":"stated","total_value":38007.24,"total_display":"38,007.24","total_whole":"38,007","shares_owned_after":171214.0,"shares_owned_after_display":"171,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-06","filed_date":"2021-10-08","scope":"insider"},{"id":4994904,"accession":"0001562180-21-006323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-006323","line_url":"/filing/0001562180-21-006323#line-3","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5404.0,"shares_display":"5,404","price_per_share":18.26,"price_display":"18.26","price_state":"stated","total_value":98677.04,"total_display":"98,677.04","total_whole":"98,677","shares_owned_after":173322.0,"shares_owned_after_display":"173,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-05","scope":"insider"},{"id":4994900,"accession":"0001562180-21-006323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-006323","line_url":"/filing/0001562180-21-006323#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":1800.0,"total_display":"1,800.00","total_whole":"1,800","shares_owned_after":178726.0,"shares_owned_after_display":"178,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-05","scope":"insider"},{"id":4994895,"accession":"0001562180-21-006323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006323","line_url":"/filing/0001562180-21-006323#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":274.0,"shares_display":"274","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4932.0,"total_display":"4,932.00","total_whole":"4,932","shares_owned_after":178826.0,"shares_owned_after_display":"178,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":4235448,"accession":"0001562180-21-006168","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-006168","line_url":"/filing/0001562180-21-006168","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11844.0,"shares_display":"11,844","price_per_share":16.863394123606888,"price_display":"16.86","price_state":"stated","total_value":199730.04,"total_display":"199,730.04","total_whole":"199,730","shares_owned_after":179718.0,"shares_owned_after_display":"179,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-09-30","scope":"insider","n_lines":2},{"id":4235441,"accession":"0001562180-21-006168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-006168","line_url":"/filing/0001562180-21-006168#line-1","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14610.0,"shares_display":"14,610","price_per_share":17.3,"price_display":"17.30","price_state":"stated","total_value":252753.0,"total_display":"252,753.00","total_whole":"252,753","shares_owned_after":190944.0,"shares_owned_after_display":"190,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-28","filed_date":"2021-09-30","scope":"insider"},{"id":4900266,"accession":"0001562180-21-006116","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-21-006116","line_url":"/filing/0001562180-21-006116#line-5","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853529","owner_name":"Russell Alan J","owner_display_name":"Russell Alan J","owner_url":"/insider/0001853529","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11594.0,"shares_display":"11,594","price_per_share":17.98,"price_display":"17.98","price_state":"stated","total_value":208460.12,"total_display":"208,460.12","total_whole":"208,460","shares_owned_after":205571.0,"shares_owned_after_display":"205,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-27","scope":"insider"}],"collapsed":true,"next_cursor":"2021-09-27|4900266","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Director, Officer (Chief Scientific Officer)","n_filings":23,"first_seen":"2021-09-27","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001853529","retrieved_at":"2026-08-22T11:25:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}